Ageing as a risk factor for neurodegenerative disease (original) (raw)

• Rose, M. R. Adaptation, aging, and genomic information. Aging 1, 444–450 (2009).
  Google Scholar
• Carmona, J. J. & Michan, S. Biology of healthy aging and longevity. Rev. Invest. Clin. 68, 7–16 (2016).
  CAS PubMed Google Scholar
• Alzheimer’s Association. 2018 Alzheimer’s disease facts and figures. Alzheimers Dement. 14, 367–429 (2018).
  Google Scholar
• Wyss-Coray, T. Ageing, neurodegeneration and brain rejuvenation. Nature 539, 180–186 (2016).
  CAS PubMed PubMed Central Google Scholar
• Elobeid, A., Libard, S., Leino, M., Popova, S. N. & Alafuzoff, I. Altered proteins in the aging brain. J. Neuropathol. Exp. Neurol. 75, 316–325 (2016).
  PubMed PubMed Central Google Scholar
• Dean, D. C., 3rd et al. Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study. JAMA Neurol. 71, 11–22 (2014).
  PubMed PubMed Central Google Scholar
• Schaefers, A. T. & Teuchert-Noodt, G. Developmental neuroplasticity and the origin of neurodegenerative diseases. World J. Biol. Psychiatry 17, 587–599 (2016).
  PubMed Google Scholar
• Nussbaum, R. L. & Ellis, C. E. Alzheimer’s disease and Parkinson’s disease. N. Engl. J. Med. 348, 1356–1364 (2003).
  CAS PubMed Google Scholar
• Hy, L. X. & Keller, D. M. Prevalence of AD among whites: a summary by levels of severity. Neurology 55, 198–204 (2000).
  CAS PubMed Google Scholar
• Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Primers 3, 17013 (2017).
  PubMed Google Scholar
• Mehta, P. et al. Prevalence of amyotrophic lateral sclerosis – United States, 2014. MMWR Morb. Mortal. Wkly. Rep. 67, 216–218 (2018).
  PubMed PubMed Central Google Scholar
• Robinson, J. L. et al. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain 141, 2181–2193 (2018).
  PubMed PubMed Central Google Scholar
• Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194–1217 (2013).
  CAS PubMed PubMed Central Google Scholar
• Chow, H. M. & Herrup, K. Genomic integrity and the ageing brain. Nat. Rev. Neurosci. 16, 672–684 (2015).
  CAS PubMed Google Scholar
• Madabhushi, R., Pan, L. & Tsai, L. H. DNA damage and its links to neurodegeneration. Neuron 83, 266–282 (2014).
  CAS PubMed PubMed Central Google Scholar
• Jeppesen, D. K., Bohr, V. A. & Stevnsner, T. DNA repair deficiency in neurodegeneration. Prog. Neurobiol. 94, 166–200 (2011).
  CAS PubMed PubMed Central Google Scholar
• Thanan, R. et al. Oxidative stress and its significant roles in neurodegenerative diseases and cancer. Int. J. Mol. Sci. 16, 193–217 (2015).
  Google Scholar
• McKinnon, P. J. Maintaining genome stability in the nervous system. Nat. Neurosci. 16, 1523–1529 (2013).
  CAS PubMed PubMed Central Google Scholar
• Maynard, S., Schurman, S. H., Harboe, C., de Souza-Pinto, N. C. & Bohr, V. A. Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis 30, 2–10 (2009).
  CAS PubMed Google Scholar
• Tell, G. & Demple, B. Base excision DNA repair and cancer. Oncotarget 6, 584–585 (2015).
  PubMed Google Scholar
• Leandro, G. S., Sykora, P. & Bohr, V. A. The impact of base excision DNA repair in age-related neurodegenerative diseases. Mutat. Res. 776, 31–39 (2015).
  CAS PubMed PubMed Central Google Scholar
• Akbari, M., Morevati, M., Croteau, D. & Bohr, V. A. The role of DNA base excision repair in brain homeostasis and disease. DNA Repair 32, 172–179 (2015).
  CAS Google Scholar
• Fang, E. F. et al. NAD(+) in aging: molecular mechanisms and translational implications. Trends Mol. Med. 23, 899–916 (2017).
  CAS PubMed PubMed Central Google Scholar
• Herrmann, M., Pusceddu, I., Marz, W. & Herrmann, W. Telomere biology and age-related diseases. Clin. Chem. Lab. Med. 56, 1210–1222 (2018).
  CAS PubMed Google Scholar
• Eitan, E., Hutchison, E. R. & Mattson, M. P. Telomere shortening in neurological disorders: an abundance of unanswered questions. Trends Neurosci. 37, 256–263 (2014).
  CAS PubMed PubMed Central Google Scholar
• Bradley-Whitman, M. A. & Lovell, M. A. Epigenetic changes in the progression of Alzheimer’s disease. Mech. Ageing Dev. 134, 486–495 (2013).
  CAS PubMed Google Scholar
• Hwang, J. Y., Aromolaran, K. A. & Zukin, R. S. The emerging field of epigenetics in neurodegeneration and neuroprotection. Nat. Rev. Neurosci. 18, 347–361 (2017).
  CAS PubMed PubMed Central Google Scholar
• Tanaka, K. & Matsuda, N. Proteostasis and neurodegeneration: the roles of proteasomal degradation and autophagy. Biochim. Biophys. Acta 1843, 197–204 (2014).
  CAS PubMed Google Scholar
• Johri, A. & Beal, M. F. Mitochondrial dysfunction in neurodegenerative diseases. J. Pharmacol. Exp. Ther. 342, 619–630 (2012).
  CAS PubMed PubMed Central Google Scholar
• Keogh, M. J. & Chinnery, P. F. Mitochondrial DNA mutations in neurodegeneration. Biochim. Biophys. Acta 1847, 1401–1411 (2015).
  CAS PubMed Google Scholar
• Greene, J. C. et al. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl Acad. Sci. USA 100, 4078–4083 (2003).
  CAS PubMed PubMed Central Google Scholar
• Pickrell, A. M. & Youle, R. J. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson’s disease. Neuron 85, 257–273 (2015).
  CAS PubMed PubMed Central Google Scholar
• Sliter, D. A. et al. Parkin and PINK1 mitigate STING-induced inflammation. Nature 561, 258–262 (2018).
  CAS PubMed PubMed Central Google Scholar
• Fivenson, E. M. et al. Mitophagy in neurodegeneration and aging. Neurochem. Int. 109, 202–209 (2017).
  CAS PubMed PubMed Central Google Scholar
• Koentjoro, B., Park, J. S. & Sue, C. M. Nix restores mitophagy and mitochondrial function to protect against PINK1/parkin-related Parkinson’s disease. Sci. Rep. 7, 44373 (2017).
  PubMed PubMed Central Google Scholar
• Di Rita, A. et al. AMBRA1-mediated mitophagy counteracts oxidative stress and apoptosis induced by neurotoxicity in human neuroblastoma SH-SY5Y cells. Front. Cell. Neurosci. 12, 92 (2018).
  PubMed PubMed Central Google Scholar
• Yun, J. et al. MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin. Elife 3, e01958 (2014).
  PubMed PubMed Central Google Scholar
• Haynes, C. M. & Ron, D. The mitochondrial UPR – protecting organelle protein homeostasis. J. Cell Sci. 123, 3849–3855 (2010).
  CAS PubMed Google Scholar
• Hayflick, L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614–636 (1965).
  CAS PubMed Google Scholar
• Kultz, D. Molecular and evolutionary basis of the cellular stress response. Annu. Rev. Physiol. 67, 225–257 (2005).
  PubMed Google Scholar
• Kuilman, T., Michaloglou, C., Mooi, W. J. & Peeper, D. S. The essence of senescence. Genes Dev. 24, 2463–2479 (2010).
  CAS PubMed PubMed Central Google Scholar
• Loaiza, N. & Demaria, M. Cellular senescence and tumor promotion: is aging the key? Biochim. Biophys. Acta 1865, 155–167 (2016).
  CAS PubMed Google Scholar
• Coppe, J. P., Desprez, P. Y., Krtolica, A. & Campisi, J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99–118 (2010).
  CAS PubMed PubMed Central Google Scholar
• Wiley, C. D. et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab. 23, 303–314 (2016).
  CAS PubMed Google Scholar
• Nacarelli, T. et al. NAD(+) metabolism governs the proinflammatory senescence-associated secretome. Nat. Cell Biol. 21, 397–407 (2019).
  CAS PubMed PubMed Central Google Scholar
• Maynard, S., Fang, E. F., Scheibye-Knudsen, M., Croteau, D. L. & Bohr, V. A. DNA damage, DNA repair, aging, and neurodegeneration. Cold Spring Harb. Perspect. Med. https://doi.org/10.1101/cshperspect.a025130 (2015).
• Barrio-Alonso, E., Hernandez-Vivanco, A., Walton, C. C., Perea, G. & Frade, J. M. Cell cycle reentry triggers hyperploidization and synaptic dysfunction followed by delayed cell death in differentiated cortical neurons. Sci. Rep. 8, 14316 (2018).
  CAS PubMed PubMed Central Google Scholar
• Fielder, E., von Zglinicki, T. & Jurk, D. The DNA damage response in neurons: die by apoptosis or survive in a senescence-like state? J. Alzheimers Dis. 60, S107–S131 (2017).
  CAS PubMed Google Scholar
• Jurk, D. et al. Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response. Aging Cell 11, 996–1004 (2012).
  CAS PubMed Google Scholar
• Vaidya, A. et al. Knock-in reporter mice demonstrate that DNA repair by non-homologous end joining declines with age. PLoS Genet. 10, e1004511 (2014).
  PubMed PubMed Central Google Scholar
• Narita, M. et al. Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 332, 966–970 (2011).
  CAS PubMed PubMed Central Google Scholar
• Gewirtz, D. A. Autophagy and senescence: a partnership in search of definition. Autophagy 9, 808–812 (2013).
  CAS PubMed PubMed Central Google Scholar
• Kang, H. T., Lee, K. B., Kim, S. Y., Choi, H. R. & Park, S. C. Autophagy impairment induces premature senescence in primary human fibroblasts. PLoS One 6, e23367 (2011).
  CAS PubMed PubMed Central Google Scholar
• Kang, C. et al. The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science 349, aaa5612 (2015).
  PubMed PubMed Central Google Scholar
• Bhatia-Dey, N., Kanherkar, R. R., Stair, S. E., Makarev, E. O. & Csoka, A. B. Cellular senescence as the causal nexus of aging. Front. Genet. 7, 13 (2016).
  PubMed PubMed Central Google Scholar
• Fontana, L., Partridge, L. & Longo, V. D. Extending healthy life span – from yeast to humans. Science 328, 321–326 (2010).
  CAS PubMed PubMed Central Google Scholar
• Babbar, M. & Sheikh, M. S. Metabolic stress and disorders related to alterations in mitochondrial fission or fusion. Mol. Cell. Pharmacol. 5, 109–133 (2013).
  PubMed PubMed Central Google Scholar
• Oh, J., Lee, Y. D. & Wagers, A. J. Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nat. Med. 20, 870–880 (2014).
  CAS PubMed PubMed Central Google Scholar
• Villeda, S. A. et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat. Med. 20, 659–663 (2014).
  CAS PubMed PubMed Central Google Scholar
• Amor, S. & Woodroofe, M. N. Innate and adaptive immune responses in neurodegeneration and repair. Immunology 141, 287–291 (2014).
  CAS PubMed PubMed Central Google Scholar
• He, F. & Balling, R. The role of regulatory T cells in neurodegenerative diseases. Wiley Interdiscip. Rev. Syst. Biol. Med. 5, 153–180 (2013).
  CAS PubMed Google Scholar
• Cao, W. & Zheng, H. Peripheral immune system in aging and Alzheimer’s disease. Mol. Neurodegener. 13, 51 (2018).
  CAS PubMed PubMed Central Google Scholar
• Giunta, S. Is inflammaging an auto[innate]immunity subclinical syndrome? Immun. Ageing 3, 12 (2006).
  PubMed PubMed Central Google Scholar
• Currais, A. Ageing and inflammation – a central role for mitochondria in brain health and disease. Ageing Res. Rev. 21, 30–42 (2015).
  CAS PubMed Google Scholar
• Lu, T. et al. Gene regulation and DNA damage in the ageing human brain. Nature 429, 883–891 (2004).
  CAS PubMed Google Scholar
• Hickman, S., Izzy, S., Sen, P., Morsett, L. & El Khoury, J. Microglia in neurodegeneration. Nat. Neurosci. 21, 1359–1369 (2018).
  CAS PubMed PubMed Central Google Scholar
• Cunningham, C. Microglia and neurodegeneration: the role of systemic inflammation. Glia 61, 71–90 (2013).
  PubMed Google Scholar
• Youm, Y. H. et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. 18, 519–532 (2013).
  CAS PubMed PubMed Central Google Scholar
• Halle, A. et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9, 857–865 (2008).
  CAS PubMed PubMed Central Google Scholar
• Codolo, G. et al. Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies. PLoS One 8, e55375 (2013).
  CAS PubMed PubMed Central Google Scholar
• Ona, V. O. et al. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington’s disease. Nature 399, 263–267 (1999).
  CAS PubMed Google Scholar
• Johann, S. et al. NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients. Glia 63, 2260–2273 (2015).
  PubMed Google Scholar
• Meissner, F., Molawi, K. & Zychlinsky, A. Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesis. Proc. Natl Acad. Sci. USA 107, 13046–13050 (2010).
  CAS PubMed PubMed Central Google Scholar
• Wang, W. Y., Tan, M. S., Yu, J. T. & Tan, L. Role of pro-inflammatory cytokines released from microglia in Alzheimer’s disease. Ann. Transl Med. 3, 136 (2015).
  PubMed PubMed Central Google Scholar
• Wang, W. et al. Caspase-1 causes truncation and aggregation of the Parkinson’s disease-associated protein α-synuclein. Proc. Natl Acad. Sci. USA 113, 9587–9592 (2016).
  CAS PubMed PubMed Central Google Scholar
• Uchoa, M. F., Moser, V. A. & Pike, C. J. Interactions between inflammation, sex steroids, and Alzheimer’s disease risk factors. Front. Neuroendocrinol. 43, 60–82 (2016).
  CAS PubMed PubMed Central Google Scholar
• Grune, T., Jung, T., Merker, K. & Davies, K. J. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and ‘aggresomes’ during oxidative stress, aging, and disease. Int. J. Biochem. Cell Biol. 36, 2519–2530 (2004).
  CAS PubMed Google Scholar
• Nakahira, K. et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12, 222–230 (2011).
  CAS PubMed Google Scholar
• Baker, D. J. & Petersen, R. C. Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives. J. Clin. Invest. 128, 1208–1216 (2018).
  PubMed PubMed Central Google Scholar
• Pan, M. R., Li, K., Lin, S. Y. & Hung, W. C. Connecting the dots: from DNA damage and repair to aging. Int. J. Mol. Sci. 17, 685 (2016).
  PubMed Central Google Scholar
• Frasca, D. & Blomberg, B. B. Inflammaging decreases adaptive and innate immune responses in mice and humans. Biogerontology 17, 7–19 (2016).
  CAS PubMed Google Scholar
• Bektas, A., Schurman, S. H., Sen, R. & Ferrucci, L. Aging, inflammation and the environment. Exp. Gerontol. 105, 10–18 (2018).
  CAS PubMed Google Scholar
• Valera, E. et al. Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy. Acta Neuropathol. Commun. 5, 2 (2017).
  PubMed PubMed Central Google Scholar
• Sevigny, J. et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature 537, 50–56 (2016).
  CAS PubMed Google Scholar
• Van Cauwenberghe, C., Vandendriessche, C., Libert, C. & Vandenbroucke, R. E. Caloric restriction: beneficial effects on brain aging and Alzheimer’s disease. Mamm. Genome 27, 300–319 (2016).
  PubMed Google Scholar
• Spielman, L. J., Little, J. P. & Klegeris, A. Physical activity and exercise attenuate neuroinflammation in neurological diseases. Brain Res. Bull. 125, 19–29 (2016).
  CAS PubMed Google Scholar
• Bekris, L. M., Yu, C. E., Bird, T. D. & Tsuang, D. W. Genetics of Alzheimer disease. J. Geriatr. Psychiatry Neurol. 23, 213–227 (2010).
  PubMed PubMed Central Google Scholar
• Liu, C. C., Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106–118 (2013).
  CAS PubMed PubMed Central Google Scholar
• Bloom, G. S. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 71, 505–508 (2014).
  PubMed Google Scholar
• Wang, J., Gu, B. J., Masters, C. L. & Wang, Y. J. A systemic view of Alzheimer disease – insights from amyloid-β metabolism beyond the brain. Nat. Rev. Neurol. 13, 612–623 (2017).
  CAS PubMed Google Scholar
• Lane, C. A., Hardy, J. & Schott, J. M. Alzheimer’s disease. Eur. J. Neurol. 25, 59–70 (2018).
  CAS PubMed Google Scholar
• Selkoe, D. J. & Hardy, J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol. Med. 8, 595–608 (2016).
  CAS PubMed PubMed Central Google Scholar
• Spillantini, M. G. & Goedert, M. Tau pathology and neurodegeneration. Lancet Neurol. 12, 609–622 (2013).
  CAS PubMed Google Scholar
• Fu, W. Y., Wang, X. & Ip, N. Y. Targeting neuroinflammation as a therapeutic strategy for Alzheimer’s disease: mechanisms, drug candidates, and new opportunities. ACS Chem. Neurosci. 10, 872–879 (2019).
  CAS PubMed Google Scholar
• Hardy, J. The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal. J. Neurochem. 110, 1129–1134 (2009).
  CAS PubMed Google Scholar
• Hall, A. M. & Roberson, E. D. Mouse models of Alzheimer’s disease. Brain Res. Bull. 88, 3–12 (2012).
  CAS PubMed Google Scholar
• Ewald, C. Y. & Li, C. Understanding the molecular basis of Alzheimer’s disease using a Caenorhabditis elegans model system. Brain Struct. Funct. 214, 263–283 (2010).
  CAS PubMed Google Scholar
• Prussing, K., Voigt, A. & Schulz, J. B. Drosophila melanogaster as a model organism for Alzheimer’s disease. Mol. Neurodegener. 8, 35 (2013).
  PubMed PubMed Central Google Scholar
• Tan, F. H. P. & Azzam, G. Drosophila melanogaster: deciphering Alzheimer’s disease. Malays. J. Med. Sci. 24, 6–20 (2017).
  PubMed PubMed Central Google Scholar
• Arber, C., Lovejoy, C. & Wray, S. Stem cell models of Alzheimer’s disease: progress and challenges. Alzheimers Res. Ther. 9, 42 (2017).
  PubMed PubMed Central Google Scholar
• Teng, E. et al. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization. Neurobiol. Dis. 82, 552–560 (2015).
  CAS PubMed PubMed Central Google Scholar
• Lovell, M. A., Gabbita, S. P. & Markesbery, W. R. Increased DNA oxidation and decreased levels of repair products in Alzheimer’s disease ventricular CSF. J. Neurochem. 72, 771–776 (1999).
  CAS PubMed Google Scholar
• Weissman, L. et al. Defective DNA base excision repair in brain from individuals with Alzheimer’s disease and amnestic mild cognitive impairment. Nucleic Acids Res. 35, 5545–5555 (2007).
  CAS PubMed PubMed Central Google Scholar
• Sykora, P. et al. DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes. Nucleic Acids Res. 43, 943–959 (2015).
  CAS PubMed Google Scholar
• Wang, H. Z. et al. Validating GWAS-identified risk loci for Alzheimer’s disease in Han Chinese populations. Mol. Neurobiol. 53, 379–390 (2016).
  CAS PubMed Google Scholar
• Fang, E. F. et al. NAD(+) replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair. Cell Metab. 24, 566–581 (2016).
  CAS PubMed PubMed Central Google Scholar
• Hou, Y. et al. NAD(+) supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proc. Natl Acad. Sci. USA 115, E1876–E1885 (2018).
  CAS PubMed PubMed Central Google Scholar
• Kwon, M. J., Kim, S., Han, M. H. & Lee, S. B. Epigenetic changes in neurodegenerative diseases. Mol. Cells 39, 783–789 (2016).
  CAS PubMed PubMed Central Google Scholar
• Ow, S. Y. & Dunstan, D. E. A brief overview of amyloids and Alzheimer’s disease. Protein Sci. 23, 1315–1331 (2014).
  CAS PubMed PubMed Central Google Scholar
• Kerr, J. S. et al. Mitophagy and Alzheimer’s disease: cellular and molecular mechanisms. Trends Neurosci. 40, 151–166 (2017).
  CAS PubMed PubMed Central Google Scholar
• Fang, E. F. et al. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nat. Neurosci. 22, 401–412 (2019).
  CAS PubMed PubMed Central Google Scholar
• Bhat, R. et al. Astrocyte senescence as a component of Alzheimer’s disease. PLoS One 7, e45069 (2012).
  CAS PubMed PubMed Central Google Scholar
• Boccardi, V., Pelini, L., Ercolani, S., Ruggiero, C. & Mecocci, P. From cellular senescence to Alzheimer’s disease: the role of telomere shortening. Ageing Res. Rev. 22, 1–8 (2015).
  CAS PubMed Google Scholar
• Chinta, S. J. et al. Cellular senescence is induced by the environmental neurotoxin paraquat and contributes to neuropathology linked to Parkinson’s disease. Cell Rep 22, 930–940 (2018).
  CAS PubMed PubMed Central Google Scholar
• Turnquist, C. et al. p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration. Cell Death Differ. 23, 1515–1528 (2016).
  CAS PubMed PubMed Central Google Scholar
• He, N. et al. Amyloid-β(1-42) oligomer accelerates senescence in adult hippocampal neural stem/progenitor cells via formylpeptide receptor 2. Cell Death Dis. 4, e924 (2013).
  CAS PubMed PubMed Central Google Scholar
• Kirkland, J. L. & Tchkonia, T. Cellular senescence: a translational perspective. EBioMedicine 21, 21–28 (2017).
  PubMed PubMed Central Google Scholar
• Bussian, T. J. et al. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 562, 578–582 (2018).
  CAS PubMed PubMed Central Google Scholar
• Zhang, P. et al. Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer’s disease model. Nat. Neurosci. 22, 719–728 (2019).
  CAS PubMed PubMed Central Google Scholar
• Musi, N. et al. Tau protein aggregation is associated with cellular senescence in the brain. Aging Cell 17, e12840 (2018).
  PubMed PubMed Central Google Scholar
• Talbot, K. et al. Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Invest. 122, 1316–1338 (2012).
  CAS PubMed PubMed Central Google Scholar
• Oddo, S. The role of mTOR signaling in Alzheimer disease. Front. Biosci. (Schol Ed) 4, 941–952 (2012).
  Google Scholar
• Salminen, A., Kaarniranta, K., Haapasalo, A., Soininen, H. & Hiltunen, M. AMP-activated protein kinase: a potential player in Alzheimer’s disease. J. Neurochem. 118, 460–474 (2011).
  CAS PubMed Google Scholar
• Camandola, S. & Mattson, M. P. Brain metabolism in health, aging, and neurodegeneration. EMBO J. 36, 1474–1492 (2017).
  CAS PubMed PubMed Central Google Scholar
• De Felice, F. G. & Lourenco, M. V. Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer’s disease. Front. Aging Neurosci. 7, 94 (2015).
  PubMed PubMed Central Google Scholar
• Cai, H. et al. Metabolic dysfunction in Alzheimer’s disease and related neurodegenerative disorders. Curr. Alzheimer Res. 9, 5–17 (2012).
  CAS PubMed PubMed Central Google Scholar
• Simons, M. et al. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc. Natl Acad. Sci. USA 95, 6460–6464 (1998).
  CAS PubMed PubMed Central Google Scholar
• Vivar, C. Adult hippocampal neurogenesis, aging and neurodegenerative diseases: possible strategies to prevent cognitive impairment. Curr. Top. Med. Chem. 15, 2175–2192 (2015).
  CAS PubMed Google Scholar
• McClean, P. L., Parthsarathy, V., Faivre, E. & Holscher, C. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer’s disease. J. Neurosci. 31, 6587–6594 (2011).
  CAS PubMed PubMed Central Google Scholar
• Ho, L. et al. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease. FASEB J. 18, 902–904 (2004).
  CAS PubMed Google Scholar
• Takamatsu, Y. et al. Combined immunotherapy with “anti-insulin resistance” therapy as a novel therapeutic strategy against neurodegenerative diseases. NPJ Parkinsons Dis. 3, 4 (2017).
  PubMed PubMed Central Google Scholar
• Heneka, M. T., Reyes-Irisarri, E., Hull, M. & Kummer, M. P. Impact and therapeutic potential of PPARs in Alzheimer’s disease. Curr. Neuropharmacol. 9, 643–650 (2011).
  CAS PubMed PubMed Central Google Scholar
• Rotermund, C., Machetanz, G. & Fitzgerald, J. C. The therapeutic potential of metformin in neurodegenerative diseases. Front. Endocrinol. 9, 400 (2018).
  Google Scholar
• Sarlus, H. & Heneka, M. T. Microglia in Alzheimer’s disease. J. Clin. Invest. 127, 3240–3249 (2017).
  PubMed PubMed Central Google Scholar
• Melki, R. Role of different alpha-synuclein strains in synucleinopathies, similarities with other neurodegenerative diseases. J. Parkinsons Dis. 5, 217–227 (2015).
  CAS PubMed PubMed Central Google Scholar
• Rocha, E. M., De Miranda, B. & Sanders, L. H. Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease. Neurobiol. Dis. 109, 249–257 (2018).
  CAS PubMed Google Scholar
• Dias, V., Junn, E. & Mouradian, M. M. The role of oxidative stress in Parkinson’s disease. J. Parkinsons Dis. 3, 461–491 (2013).
  CAS PubMed PubMed Central Google Scholar
• Hirsch, E. C. & Hunot, S. Neuroinflammation in Parkinson’s disease: a target for neuroprotection? Lancet Neurol. 8, 382–397 (2009).
  CAS PubMed Google Scholar
• Sepe, S. et al. Inefficient DNA repair is an aging-related modifier of Parkinson’s disease. Cell Rep. 15, 1866–1875 (2016).
  CAS PubMed PubMed Central Google Scholar
• Labbe, C., Lorenzo-Betancor, O. & Ross, O. A. Epigenetic regulation in Parkinson’s disease. Acta Neuropathol. 132, 515–530 (2016).
  CAS PubMed PubMed Central Google Scholar
• Curry, D. W., Stutz, B., Andrews, Z. B. & Elsworth, J. D. Targeting AMPK signaling as a neuroprotective strategy in Parkinson’s disease. J. Parkinsons Dis. 8, 161–181 (2018).
  PubMed PubMed Central Google Scholar
• Alecu, I. & Bennett, S. A. L. Dysregulated lipid metabolism and its role in α-synucleinopathy in Parkinson’s disease. Front. Neurosci. 13, 328 (2019).
  PubMed PubMed Central Google Scholar
• Regensburger, M., Prots, I. & Winner, B. Adult hippocampal neurogenesis in Parkinson’s disease: impact on neuronal survival and plasticity. Neural Plast. 2014, 454696 (2014).
  PubMed PubMed Central Google Scholar
• Kikuchi, T. et al. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model. Nature 548, 592–596 (2017).
  CAS PubMed Google Scholar
• McGeer, P. L., Itagaki, S., Boyes, B. E. & McGeer, E. G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology 38, 1285–1291 (1988).
  CAS PubMed Google Scholar
• McKinnon, P. J. ATM and ataxia telangiectasia. EMBO Rep. 5, 772–776 (2004).
  CAS PubMed PubMed Central Google Scholar
• Walter, J. T., Alvina, K., Womack, M. D., Chevez, C. & Khodakhah, K. Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat. Neurosci. 9, 389–397 (2006).
  CAS PubMed Google Scholar
• Valentin-Vega, Y. A. et al. Mitochondrial dysfunction in ataxia-telangiectasia. Blood 119, 1490–1500 (2012).
  CAS PubMed PubMed Central Google Scholar
• Guo, Z., Kozlov, S., Lavin, M. F., Person, M. D. & Paull, T. T. ATM activation by oxidative stress. Science 330, 517–521 (2010).
  CAS PubMed Google Scholar
• Hardiman, O. et al. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers 3, 17071 (2017).
  PubMed Google Scholar
• Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Primers 1, 15005 (2015).
  PubMed Google Scholar
• Karikkineth, A. C., Scheibye-Knudsen, M., Fivenson, E., Croteau, D. L. & Bohr, V. A. Cockayne syndrome: clinical features, model systems and pathways. Ageing Res. Rev. 33, 3–17 (2017).
  CAS PubMed Google Scholar
• Penndorf, D., Witte, O. W. & Kretz, A. DNA plasticity and damage in amyotrophic lateral sclerosis. Neural Regen. Res. 13, 173–180 (2018).
  PubMed PubMed Central Google Scholar
• Cai, Z., Yan, L. J. & Ratka, A. Telomere shortening and Alzheimer’s disease. Neuromol. Med. 15, 25–48 (2013).
  CAS PubMed Google Scholar
• Linkus, B. et al. Telomere shortening leads to earlier age of onset in ALS mice. Aging 8, 382–393 (2016).
  CAS Google Scholar
• Kota, L. N. et al. Reduced telomere length in neurodegenerative disorders may suggest shared biology. J. Neuropsychiatry Clin. Neurosci. 27, e92–e96 (2015).
  PubMed Google Scholar
• Block, R. C., Dorsey, E. R., Beck, C. A., Brenna, J. T. & Shoulson, I. Altered cholesterol and fatty acid metabolism in Huntington disease. J. Clin. Lipidol. 4, 17–23 (2010).
  PubMed PubMed Central Google Scholar
• Allen, D. M. et al. Ataxia telangiectasia mutated is essential during adult neurogenesis. Genes Dev. 15, 554–566 (2001).
  CAS PubMed PubMed Central Google Scholar
• Amariglio, N. et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 6, e1000029 (2009).
  PubMed PubMed Central Google Scholar
• Sapp, E. et al. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J. Neuropathol. Exp. Neurol. 60, 161–172 (2001).
  CAS PubMed Google Scholar
• Henkel, J. S. et al. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol. 55, 221–235 (2004).
  CAS PubMed Google Scholar
• Hui, C. W., Song, X., Ma, F., Shen, X. & Herrup, K. Ibuprofen prevents progression of ataxia telangiectasia symptoms in ATM-deficient mice. J. Neuroinflammation 15, 308 (2018).
  CAS PubMed PubMed Central Google Scholar
• Chow, H. M. et al. ATM is activated by ATP depletion and modulates mitochondrial function through NRF1. J. Cell Biol. 218, 909–928 (2019).
  CAS PubMed PubMed Central Google Scholar
• Chen, J. et al. The impact of glutamine supplementation on the symptoms of ataxia-telangiectasia: a preclinical assessment. Mol. Neurodegener. 11, 60 (2016).
  PubMed PubMed Central Google Scholar
• Trammell, S. A. et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun. 7, 12948 (2016).
  CAS PubMed PubMed Central Google Scholar
• Zhang, H. et al. NAD(+) repletion improves mitochondrial and stem cell function and enhances life span in mice. Science 352, 1436–1443 (2016).
  CAS PubMed Google Scholar
• Gomes, A. P. et al. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155, 1624–1638 (2013).
  CAS PubMed PubMed Central Google Scholar
• De Jesus-Cortes, H. et al. Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease. Proc. Natl Acad. Sci. USA 109, 17010–17015 (2012).
  PubMed PubMed Central Google Scholar
• Phelan, M. J., Mulnard, R. A., Gillen, D. L. & Schreiber, S. S. Phase II clinical trial of nicotinamide for the treatment of mild to moderate Alzheimer’s disease. J. Geriatr. Med. Gerontol. 3, 021 (2017).
  Google Scholar
• Ryu, D. et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat. Med. 22, 879–888 (2016).
  CAS PubMed Google Scholar
• Georgakopoulos, N. D., Wells, G. & Campanella, M. The pharmacological regulation of cellular mitophagy. Nat. Chem. Biol. 13, 136–146 (2017).
  CAS PubMed Google Scholar
• Albani, D., Polito, L., Signorini, A. & Forloni, G. Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 36, 370–376 (2010).
  CAS PubMed Google Scholar
• Heilman, J., Andreux, P., Tran, N., Rinsch, C. & Blanco-Bose, W. Safety assessment of urolithin A, a metabolite produced by the human gut microbiota upon dietary intake of plant derived ellagitannins andellagic acid. Food Chem. Toxicol. 108, 289–297 (2017).
  CAS PubMed Google Scholar
• Moreira, O. C. et al. Mitochondrial function and mitophagy in the elderly: effects of exercise. Oxid. Med. Cell. Longev. 2017, 2012798 (2017).
  PubMed PubMed Central Google Scholar
• Herranz, N. et al. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat. Cell Biol. 17, 1205–1217 (2015).
  CAS PubMed PubMed Central Google Scholar
• Walters, H. E., Deneka-Hannemann, S. & Cox, L. S. Reversal of phenotypes of cellular senescence by pan-mTOR inhibition. Aging 8, 231–244 (2016).
  CAS Google Scholar
• Katila, N. et al. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson’s disease. Neuropharmacology 125, 396–407 (2017).
  CAS PubMed Google Scholar
• Ou, Z. et al. Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice. Brain. Behav. Immun. 69, 351–363 (2018).
  CAS PubMed Google Scholar
• Naylor, R. M., Baker, D. J. & van Deursen, J. M. Senescent cells: a novel therapeutic target for aging and age-related diseases. Clin. Pharmacol. Ther. 93, 105–116 (2013).
  CAS PubMed Google Scholar
• Krimpenfort, P. & Berns, A. Rejuvenation by therapeutic elimination of senescent cells. Cell 169, 3–5 (2017).
  CAS PubMed Google Scholar
• Chiti, F. & Dobson, C. M. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu. Rev. Biochem 86, 27–68 (2017).
  CAS PubMed Google Scholar
• Jack, C. R. Jr. et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 14, 535–562 (2018).
  PubMed PubMed Central Google Scholar
• Medina, M. An overview on the clinical development of tau-based therapeutics. Int. J. Mol. Sci. 19, 1160 (2018).
  PubMed Central Google Scholar
• Braak, H. & Braak, E. Evolution of the neuropathology of Alzheimer’s disease. Acta Neurol. Scand. Suppl. 165, 3–12 (1996).
  CAS PubMed Google Scholar
• Cummings, J., Lee, G., Ritter, A. & Zhong, K. Alzheimer’s disease drug development pipeline: 2018. Alzheimers Dement. 4, 195–214 (2018).
  Google Scholar
• Cao, B. et al. Comparative efficacy and acceptability of antidiabetic agents for Alzheimer’s disease and mild cognitive impairment: a systematic review and network meta-analysis. Diabetes Obes. Metab. 20, 2467–2471 (2018).
  PubMed Google Scholar
• Miguel-Alvarez, M. et al. Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer’s disease: a systematic review and meta-analysis of treatment effect. Drugs Aging 32, 139–147 (2015).
  CAS PubMed Google Scholar
• Rees, K. et al. Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson’s disease: evidence from observational studies. Cochrane Database of Systematic Reviews 9, CD008454 (2011).
  Google Scholar
• US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02588677 (2018).
• Petrov, D., Mansfield, C., Moussy, A. & Hermine, O. ALS clinical trials review: 20 years of failure. are we any closer to registering a new treatment? Front. Aging Neurosci. 9, 68 (2017).
  PubMed PubMed Central Google Scholar
• Vaiserman, A. M., Lushchak, O. V. & Koliada, A. K. Anti-aging pharmacology: promises and pitfalls. Ageing Res. Rev. 31, 9–35 (2016).
  PubMed Google Scholar
• Hernandez-Camacho, J. D., Bernier, M., Lopez-Lluch, G. & Navas, P. Coenzyme Q10 supplementation in aging and disease. Front. Physiol. 9, 44 (2018).
  PubMed PubMed Central Google Scholar
• Li, T. & Chen, Z. J. The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer. J. Exp. Med. 215, 1287–1299 (2018).
  CAS PubMed PubMed Central Google Scholar
• Giraldez-Perez, R., Antolin-Vallespin, M., Munoz, M. & Sanchez-Capelo, A. Models of α-synuclein aggregation in Parkinson’s disease. Acta Neuropathol. Commun. 2, 176 (2014).
  PubMed PubMed Central Google Scholar
• Reitz, C. & Mayeux, R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem. Pharmacol. 88, 640–651 (2014).
  CAS PubMed PubMed Central Google Scholar
• Vina, J. & Lloret, A. Why women have more Alzheimer’s disease than men: gender and mitochondrial toxicity of amyloid-β peptide. J. Alzheimers Dis. 20, S527–S533 (2010).
  PubMed Google Scholar
• Luchsinger, J. A. et al. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65, 545–551 (2005).
  CAS PubMed Google Scholar
• Grant, W. B., Campbell, A., Itzhaki, R. F. & Savory, J. The significance of environmental factors in the etiology of Alzheimer’s disease. J. Alzheimers Dis. 4, 179–189 (2002).
  PubMed Google Scholar
• Kalia, L. V. & Lang, A. E. Parkinson’s disease. Lancet 386, 896–912 (2015).
  CAS PubMed Google Scholar
• Weintraub, D. & Stern, M. B. Psychiatric complications in Parkinson disease. Am. J. Geriatr. Psychiatry 13, 844–851 (2005).
  PubMed Google Scholar
• Mak, E. et al. Cognitive deficits in mild Parkinson’s disease are associated with distinct areas of grey matter atrophy. J. Neurol. Neurosurg. Psychiatry 85, 576–580 (2014).
  PubMed Google Scholar
• Talbott, E. O., Malek, A. M. & Lacomis, D. The epidemiology of amyotrophic lateral sclerosis. Handb. Clin. Neurol. 138, 225–238 (2016).
  CAS PubMed Google Scholar
• Walker, F. O. Huntington’s disease. Lancet 369, 218–228 (2007).
  CAS PubMed Google Scholar
• Subramaniam, S., Sixt, K. M., Barrow, R. & Snyder, S. H. Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 324, 1327–1330 (2009).
  CAS PubMed PubMed Central Google Scholar
• Duff, K. et al. Psychiatric symptoms in Huntington’s disease before diagnosis: the Predict-HD study. Biol. Psychiatry 62, 1341–1346 (2007).
  PubMed Google Scholar
• Zweig, Y. R. & Galvin, J. E. Lewy body dementia: the impact on patients and caregivers. Alzheimers Res. Ther. 6, 21 (2014).
  PubMed PubMed Central Google Scholar
• Rothblum-Oviatt, C. et al. Ataxia telangiectasia: a review. Orphanet J. Rare Dis. 11, 159 (2016).
  PubMed PubMed Central Google Scholar
• Kleijer, W. J. et al. Incidence of DNA repair deficiency disorders in western Europe: xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. DNA Repair 7, 744–750 (2008).
  CAS Google Scholar